Prof. Özgür Şanlı is a prominent name in the field of nuclear medicine, with a distinguished career built on academic excellence, clinical innovation, and a profound commitment to improving diagnostic and therapeutic approaches for complex medical conditions. Based at Izmir Economy University Medicalpoint Hospital, Prof. Şanlı brings decades of experience and specialization to the forefront of modern medicine, making him one of the most respected figures in the evolving domain of molecular imaging and radionuclide therapy.
Educational Background and Professional Development
Prof. Şanlı’s journey into the field of nuclear medicine began at Ege University Faculty of Medicine, where he earned his medical degree in 1996. His passion for advanced diagnostic tools and therapeutic technologies led him to specialize in nuclear medicine, completing his residency at the same institution in 2001. His academic path continued to ascend with an associate professorship in 2008 and full professorship in 2014 at Ege University’s Department of Nuclear Medicine.
Throughout this academic trajectory, Prof. Şanlı has been immersed in both clinical application and research, developing a well-rounded expertise that bridges conventional diagnostics with cutting-edge therapeutic innovations.
Clinical and Academic Experience
Prof. Şanlı’s professional career spans over two decades, during which he served in multiple academic roles at Ege University Faculty of Medicine’s Department of Nuclear Medicine:
- 1996–2001: Research Assistant
- 2001–2008: Specialist Doctor
- 2008–2014: Associate Professor
- 2014–2023: Full Professor
This extensive tenure not only reflects a deep command of nuclear medicine but also a sustained contribution to teaching and training future medical professionals. Today, at Izmir Economy University Medicalpoint Hospital, he continues his mission by providing high-level patient care using advanced nuclear medicine techniques.
Areas of Specialization
Prof. Özgür Şanlı specializes in diagnostic imaging and therapeutic applications of nuclear medicine, with extensive experience in PET-CT, radionuclide imaging, and scintigraphic techniques. His diagnostic expertise is critical in managing complex and elusive diseases such as:
- Sarcoidosis
- Meningioma
- Paraganglioma
- Goiter and Thyroiditis
- Thyroid Cancer
- Prostate Cancer
- Primary and Metastatic Liver Tumors
By leveraging nuclear imaging technologies, Prof. Şanlı provides unparalleled accuracy in localizing and characterizing various pathologies, thereby influencing treatment decisions and outcomes for countless patients.
Advanced Treatment Modalities
In the realm of theranostics, Prof. Şanlı is renowned for employing targeted radionuclide therapies that not only visualize disease but also treat it at the cellular level. His advanced treatment portfolio includes:
- Actinium-225 PSMA Therapy
- Lu-177 PSMA Therapy
- Lu-177 DOTATATE Therapy
- Lu-177 EDTMP
- Radium-223 Therapy
- Phosphorus-32 Therapy
- Radioactive Iodine Treatment (RAI)
- Transarterial Radionuclide Therapy with Y-90 Microspheres
These therapies represent the future of precision oncology, offering new hope for patients with metastatic cancers and neuroendocrine tumors. Prof. Şanlı’s mastery of these complex treatments ensures safe, evidence-based care for individuals who require highly specialized interventions.
Commitment to Multidisciplinary Care
A key differentiator in Prof. Şanlı’s approach is his active participation in multidisciplinary oncology care, working closely with oncologists, radiologists, surgeons, and pathologists to provide integrated treatment plans. His memberships in leading professional associations reflect this collaborative mindset:
- Nuclear Medicine Association
- Urooncology Association
- Multidisciplinary Oncology Association
- Academic Oncology Association
Through this framework, Prof. Şanlı ensures that every patient benefits from a team-based strategy, grounded in clinical evidence and medical consensus.
Notable Achievements and Recognition
Prof. Özgür Şanlı’s contributions to nuclear medicine have not gone unnoticed. His receipt of various awards and certifications underscores a career characterized by innovation, leadership, and service to both patients and the medical community. These honors reinforce his status as a leader in nuclear medicine and a trusted expert in precision cancer care.
Why Patients and Professionals Trust Prof. Şanlı
Patients seek out Prof. Şanlı not only for his medical acumen but also for his dedication to compassionate care. Whether conducting a complex PET-CT scan or managing a patient through multiple cycles of radionuclide therapy, he maintains an unwavering focus on safety, effectiveness, and individual well-being.
Medical professionals, on the other hand, view him as a mentor, researcher, and thought leader. His academic rigor and commitment to continuous learning have made him an influential figure in Turkey’s medical education landscape.
With over 25 years of dedication to nuclear medicine, Prof. Özgür Şanlı stands as a pillar of expertise in both diagnostic and therapeutic nuclear applications. His command over cutting-edge technologies like PET-CT, Lu-177 therapies, and transarterial radionuclide therapy places him among the elite professionals in this highly specialized field. As he continues his work at Izmir Economy University Medicalpoint Hospital, patients can expect world-class care underpinned by innovation, precision, and compassion.
Learn more about Prof. Özgür Şanlı’s expertise, surgical specialties, and patient care philosophy on his official profile at Better by MTA. View Profile »
Request a Free Quote
If you’re considering treatment with Prof. Özgür Şanlı, you can request a free, no-obligation quote by clicking here.
.png)
